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mpalakal@iupui.edu (M.J Palakal).Health social networking communities are emerging resources for translational research. We have
designed and implemented a framework called HyGen, which combines Semantic Web technologies,
graph algorithms and user proﬁling to discover and prioritize novel associations across disciplines. This
manuscript focuses on the key strategies developed to overcome the challenges in handling patient-
generated content in Health social networking communities. Heuristic and quantitative evaluations were
carried out in colorectal cancer. The results demonstrate the potential of our approach to bridge silos and
to identify hidden links among clinical observations, drugs, genes and diseases. In Amyotrophic Lateral
Sclerosis case studies, HyGen has identiﬁed 15 of the 20 published disease genes. Additionally, HyGen
has highlighted new candidates for future investigations, as well as a scientiﬁcally meaningful connection
between riluzole and alcohol abuse.
 2011 Elsevier Inc. All rights reserved.1. Introduction
Health social networking communities (HSNC) are online com-
munities where users search, self-track, share and discuss health-
related information using Web2.0 technologies. Examples of popu-
lar HSNC include PatientsLikeMe.com (PLM), DailyStrength.org and
MedHelp.org. Their primary users are patients with similar medical
conditions. Content embedded in HSNC is adding a new category
and dimension of information for translational research. For exam-
ple, 5% of all Amyotrophic Lateral Sclerosis (ALS) patients in the US
are registered members of PLM [1]. The data generated by those
patients could arguably be the largest data set for ALS genotype–
phenotype research. However, few studies have been devoted to
explore the potentials and challenges in using HSNC as data
sources in translational research.
The ﬁrst challenge in handling HSNC content is the consumer-
professional vocabulary gap. Vocabularies used by patients in
HSNC are consumer English. On the other hand, most biomedical
databases and tools are intended for professionals and use scien-
tiﬁc vocabularies. For example, PLM allows patients to describe
their conditions using folksonomy, a user-generated taxonomy.ll rights reserved.
munities; ALS, Amyotrophic
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ra@lilly.com (R.C Gudivada),Less than half of those symptoms mapped to the concepts or syn-
onyms in Uniﬁed Medical Language System (UMLS) [2].
Secondly, information in HSNC is organized and stratiﬁed by
consumers using Web2.0 tools such as collaborative ﬁltering, tag-
ging, and voting. The data schema is derived bottom-up from the
data, thus reﬂecting how patients understand and categorize
biomedical knowledge. But when building traditional biological
databases, we design the schema ﬁrst and then load the data.
Therefore, it is not a surprise that 62% of the symptoms submitted
by PLM patients were not ‘‘Signs or Symptoms’’ in UMLS [2].
With over 20 large HSNC websites being launched in the last
few years [3], there is an increasing need for novel tools and meth-
ods to address these challenges. We previously proposed a proto-
type for identifying hidden associations related to colorectal
cancer using information extracted from traditional biomedical
databases [4]. Based on the initial prototype, we have designed
and implemented novel strategies to overcome the challenges in
HSNC content. This manuscript presents the completed frame-
work, named HyGen, focusing on how the community-level data
in PLM is processed and utilized. In addition, it describes our quan-
titative evaluations, proposes an optimization method, and dis-
cusses the preliminary results.2. Related work
Graph analysis has drawn much interest among bioinformatics
researchers due to the rapid growth of publicly available high
throughput data [5–12]. Such data have provided linkages among
Table 1
Associations in the full graph.
Associations Count Source database
Gene and clinical
features
150,292 OMIM (www.ncbi.nlm.nih.gov)
GAD (http://geneticassociationdb.nih.
gov)
PharmGKB (www.pharmgkb.org)
Gene and gene 310,842 BioGrid (thebiogrid.org)
BIND (bond.unleashedinformatics.com)
MINT (mint.bio.uniroma2.it)
IntAct (www.ebi.ac.uk/intact)
Reactome (reactome.org)
Gene and pathway 91,771 KEGG (www.genome.jp/kegg)
Reactome (www.reactome.org)
WikiPathways
(www.wikipathways.org)
Panther (www.pantherdb.org)
PID (pid.nci.nih.gov)
GeneGo (www.genego.com)
Drug and gene 6552 DrugBank (www.drugbank.ca)
PharmGKB (www.pharmgkb.org)
Drug and clinical
features
6742 DrugBank (www.drugbank.ca)
PharmGKB (www.pharmgkb.org)
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nodes and their relationships as edges (links). The graphs can then
be analyzed using conventional graph analysis technique or exten-
sion of it [11–15].
In this case, we are especially interested in applying graph algo-
rithms to rank search results. Common approaches [16–19] include
concept structure analysis, PageRank, and Hyperlink-Induced Topic
Search (HITS). PageRank with Priors proposed by White and Smyth
[20] simulates the steps of a Web surfer, who starts from any of the
root nodes on the Internet and follows a random link at each step
with b as the probability of returning to the root nodes. A score is
computed for each node on the Internet to reﬂect its probability of
being reached by the surfer. This score is used to measure the rel-
ative ‘‘closeness’’ of a node to the root nodes. K-Step Markov meth-
od simulates a similar Web surﬁng scenario as in PageRank, except
that the surfer returns to the root nodes after K steps and restarts
the process. K-Step Markov algorithm estimates the relative prob-
ability that a surfer will spend time at a node given that the surfer
starts in a set of root nodes and stops after K steps. HITS with Priors
proposed by Kleinberg measures two properties of a node: (1)
authority score estimates the importance of the node itself; and
(2) hub score measures the importance of other nodes linked to
the current node [21]. Therefore, HITS with Priors not only consid-
ers the number of links to and from a node but also its neighbours’.
Gudivada et al. have proposed a modiﬁed algorithm to rank
genes [22]. In traditional WWW ranking analyses, all links are con-
sidered equally signiﬁcant. But in the context of biological net-
works, the importance of a link also depends on the nodes
connected with it. Using gene and pathway association as an
example, Gudivada explained that a gene participates in multiple
pathways is more important than a pathway that has multiple
genes since most pathways will include multiple genes. To model
this nature of biological networks, each link is assigned a subjectiv-
ity weight and an objectivity weight. Link such as ‘Gene-HasAssoci-
ated-Pathway’ is assigned a higher subjectivity weight (for gene)
and lower objectivity weight (for pathway). The only constraint
is that for each link the sum of subjectivity and objectivity weights
must be equal to 1.
Although concepts and technologies supporting semantic
ranking have been studied by many researchers mentioned above,
fewer reports have been published on applying user proﬁling
and sub-graphing technologies to rank multi-level and cross-
disciplinary biomedical data based on graph attributes. This ap-
proach integrates many types of nodes to discover associations
among different types of biomedical entities and to deliver the
results based on each user’s interest.3. Methods
HyGen combines Semantic Web (SW), graph algorithm and user
proﬁling to discover novel associations. The discovery process has
two main steps: (1) constructing a full semantic graph using asso-
ciations extracted from heterogeneous sources; (2) subtracting a
sub graph and ranking the associations based on the criteria de-
ﬁned by the user.3.1. Constructing a weighted graph
Using the method proposed in [23], associations were extracted
from well-known genomic, pharmacological and proteomic dat-
abases. A summary of the compiled associations is displayed in
Table 1. Those associations were converted to nodes and edges in
the full graph, where nodes represent life science entities, such
as genes, diseases, or compounds; and edges represent the rela-
tionships between entities. Numerical weights (from 0 to 1) wereassigned to the edges based on the conﬁdence scores of the data
sources. Users can adjust the conﬁdence score of a source accord-
ing to their own experience and needs in the user proﬁles.
In the full semantic graph, the Uniform Resource Identiﬁer (URI)
of an entity is derived from NIH authoritative identiﬁers, such as
EntrezGene ID or UMLS CUI. Thus, entities sharing the same URI
are merged into one node regardless of their sources, and two
nodes from different disciplines are associated if they both connect
to the same node. It is worth mentioning that even though we used
Semantic Web technologies here, the full graph can be constructed
by any other technologies as long as they allow HyGen to merge
and connect entities from diverse sources.
3.2. Converting patient-reported terms to nodes
In PLM, individual-level data is aggregated and reﬂected in the
community reports. We extracted the most frequently reported
(MFR) symptoms from ALS community report provided by PLM
[24]. We normalized the symptom terms against UMLS [25] using
MetaMap [26], followed by manual inspection. The top ten MFR
symptoms and the matching UMLS concepts are displayed in
Table 2. Similarly, we extracted MFR prescription drug names from
the ALS community report [27] and normalized them against com-
pounds or synonyms in CHEMLIST, a dictionary for identifying
chemical information in the literature [28].
Thus each patient-reported term was mapped to the node that
represents the same clinical concept or chemical substance in the
full graph. Mapping of instance-level data is HyGen’s key strategy
to bridge the consumer-professional vocabulary gap. Ontologies
such as UMLS, CHEMLIST and their companion linguistic tools, in
combination with SW, have made it possible to aggregate HSNC
content with data from research-oriented resources.
The other challenge mentioned previously is that more than
half of the symptoms submitted by PLM patients were not ‘‘Signs
or Symptoms’’ in UMLS. We circumvented this problem by deﬁning
one general type called ‘‘clinical-feature’’ for concepts belonging to
multiple UMLS semantic types. The relationships between clinical-
features and other types of nodes were loosely deﬁned (e.g. ‘‘rela-
ted_to_gene’’ and ‘‘related_to_drug’’). Obviously, the penalty of this
approach is a higher false positive rate. To compensate, we imple-
mented a pseudo relevance feedback strategy to reduce the irrele-
vant connections.
Table 2
Most frequently reported symptoms by ALS patients in PLM.
MFR
symptom
UMLS concept CUI UMLS type
Fatigue Actual fatigue C2364051 Finding
Fatigue C0015672 Sign or symptom
Fatigue C2024893 Finding
Fasciculations Muscular
fasciculation
C0015644 Sign or symptom
Stiffness/
spasticity
Stiffness C0427008 Sign or symptom
Muscle spasticity C0026838 Sign or symptom
Anxiety Anxiety symptoms C0860603 Finding
Emotional
lability
Mood swings C0085633 Mental or Behavioral
Dysfunction
Excess saliva Sialorrhea C0037036 Disease or Syndrome
Depression Actual depression C2364072 Finding
Depressed-symptom C1579931 Sign or symptom
Depressed mood C0344315 Finding
Depressive disorder C0011581 Mental or Behavioral
Dysfunction
Depressive episode,
unspeciﬁed
C0349217 Mental or Behavioral
Dysfunction
Mental depression C0011570 Mental or Behavioral
Dysfunction
Pain Actual pain C2364139 Finding
Pain C0030193 Sign or symptom
Insomnia Sleeplessness C0917801 Sign or symptom
Constipation Constipation C0009806 Sign or symptom
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Based on the full graph, different virtual sub graphs are con-
structed for different user proﬁles. A user proﬁle deﬁnes the
weights of the edges, the ranking criteria, as well as the seeds,
which are special nodes that the user is interested in, such as
‘‘fatigue’’ (a symptom), ‘‘SOD1’’ (a gene), or ‘‘riluzole’’ (a drug).
Those nodes are the starting points of the knowledge discovery,
hence the name ‘‘seeds’’.
A sub graph is constructed by an iterative process. A node is in
one of the two states during this process: discovered or undiscov-
ered, with the initial state being undiscovered except for the seeds.
HyGen starts by traversing the full graph to ﬁnd all the neighbours1
of the seeds and changes their state to discovered. HyGen then per-
forms graph analysis to rank all the discovered nodes based on the
user’s criteria. The state of any low ranking node is turned back to
undiscovered. This counts as one iteration. HyGen repeats the process
until it has reached the maximum number of iterations deﬁned in
the proﬁle, or until it has exhausted all nodes in the full graph,
whichever happens ﬁrst. At the end of the ﬁnal iteration, all the dis-
covered nodes and their edges form the virtual sub graph speciﬁc to
the given user proﬁle.
The state diagram in Fig. 1 illustrates how one node’s state is
inﬂuenced by the node’s ranking and by the states of the neighbour
nodes in each iteration. The algorithm is inspired by the pseudo
relevance feedback strategy used by document retrieval systems.
However, our goal is to reduce false positives caused by the
loosely-structured HSNC content. Instead of query expansion in
document retrieval, HyGen uses pseudo relevance feedback to re-
ﬁne the sub graph.3.4. Criteria for ranking nodes
One of the key steps of pseudo- relevance feedback algorithm is
to rank and re-rank nodes based on graph analysis. The rank of a1 Two nodes are neighbors if they are connected by one edge in the graph.node v is computed as the weighted mean of seven factors, each
of which has a value between 0 and 1. Assuming v is a concept
found to be linked to one or more seeds by one or more edges,
the deﬁnition and calculation of each factor can be found in
Table 3. The calculation of each criterion is followed by a smooth-
ing process: a sigmoid (upward) function is used on criteria for
which user prefers higher value; a sigmoid (downward) function
on ones for which user prefers lower value; and Gaussian function
on criteria for which user prefers values within a certain range.
Users can further control the ranking by adjusting weights k1 to
k7 in their proﬁles. The ﬁnal score is computed by Eq. (1). The node
with the highest score achieves the top ranking.
XSA ¼
Pn
i¼1wixiPn
i¼1wi
;X ¼ fCSA; SSA;RSA; PSA; LSA; TSA; FSAg and
W ¼ fk1;    ; k7g: ð1Þ
Once the sub graph is constructed, HyGen can issue semantic
queries against it. The results are ranked based on the same criteria
and weights described above. HyGen generates two types of
outputs. One is a set of spreadsheets of sorted associations, with
the top 5% of the associations being the ‘‘suggested ﬁndings’’. The
spreadsheets contain details about each association (not just the
top 5%) including various graph attributes, scores, shortest path
to the seeds and other computed properties.
HyGen’s other output ﬁle is an annotated sub graph ﬁle view-
able in CytoScape (www.cytoscape.org). The interactive graph ses-
sion enables scientists to visually inspect the suggested ﬁndings or
focus on interesting motifs of the sub graph. For example, in one of
the colorectal cancer (CRC) case studies, HyGen suggested a link
between CRC and Neural Tube Defects (NTD). The connections in
the sub graph seem possible. Folate supplements have been used
to prevent NTD [30,31]. There are studies claiming that folate
may also lower CRC risk [32,33]. Zooming into the sub graph, we
noticed that mutation in TP53 is linked to increase risk of CRC;
TP53 is a gene encoding tumor protein p53, which is involved in
DNA repair and changes in metabolism; TP53 connects to MTHFR
via a drug that is a pyrimidine analogue and inhibits the cell’s abil-
ity to synthesize DNA; and MTHFR polymorphism is linked to an
increased risk for NTD. Those links suggest that CRC and NTD path-
ways may share some common components.4. Evaluation
4.1. Capturing treatment–symptom correlation
The initial full graph of HyGen has been compiled from tradi-
tional research-oriented data sources, whose content is the result
of systematic research and analysis. On the other hand, HSNC con-
tent is the by-products of health care. The associations among
HSNC entities reﬂect the ‘real-world’ health care practice. We de-
sire to test whether HyGen can identify associations emerged from
health care practice based on knowledge extracted from traditional
life science data sources. In other words, starting from MFR drugs
in PLM, we expect HyGen to identify the MFR symptoms from
the full graph and to rank them high. Similarly, we expect HyGen
to highlight the proper MFR drugs in the full graph given the
MFR symptoms of PLM.
The statistical signiﬁcance (p-value) was obtained by permuta-
tion testing. To establish independent permutations, we con-
structed 104 random graphs by reassigning the edges between
nodes in the full graph. We ran HyGen against the real graph and
saved the result as the observed statistic.2 We then ran HyGen2 For all evaluations, we used the same set of criteria recommended by the domain
xperts. The values of the criteria are reported in Table 4.e
Fig. 1. State diagram of a node. At any iteration, a node enters discovered state if it is connected to a discovered node from the previous iteration. It enters undiscovered state
if it is ranked low. Therefore, a node may change state twice in one iteration.
Table 3
Ranking Criteria.
Meaning Value
CSA How relevant is v If v is the data type that user is interested in then CSA = 1; otherwise CSA = 0
SSA How speciﬁc is v, e.g. ‘‘Epithelial Neoplasm’’ is
more speciﬁc than ‘‘Neoplasm’’
SSA = Hv/H, where Hv is the position of v in the domain ontology and H is the total height of the branch where v
is found
TSA How important are the sources Average source weights of all edges
FSA How fresh is the information The time difference between now and when the triples containing v ﬁrst entered its source. Analyses
conducted at different times may produce different rankings due to the aging of the information
LSA Distance from v to the seeds Average shortest path from v to the seeds
RSA How rare is v RSA = |N|/|M|
N = number of nodes that are of the same semantic type as v. M = number of nodes in the full graph
PSA v’s probability of being reached from the seeds PageRank with priors was computed by the following iterative equation [29]:
pðvÞðiþ1Þ ¼ ð1 bÞðPdinðvÞu¼1 pðv juÞpðiÞÞ þ bPv
pvwas set to 1/|R| for all seeds and 0 for the rest. 0 < b < 1, din(v) is the in-degree of a v. p(v|u) is the probability
of reaching v from another node u. We assigned p(v) 0 to 1 for all nodes in the ﬁrst iteration
HITS with Priors was computed by the following iterative equation [29]:
aðiþ1Þ ¼ ð1 bÞ PdinðvÞu¼1 hðtÞ ðuÞHðiÞ
 
þ bPv ; andhðiþ1Þ ¼ ð1 bÞ
Pdout ðvÞ
u¼1
aðtÞ ðuÞ
AðiÞ
þ bPv
 
HðiÞ ¼PjV jv¼1PdinðvÞu¼1 hðiÞðuÞ; andAðiÞ ¼PjV jv¼1Pdout ðvÞu¼1 aðiÞðuÞ
din(v) and dout(v) are the in-degree and out-degree of v. We assigned a0 and h0 to 1 in the ﬁrst iteration
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mutation as success if it achieved similar or better results than the
real graph. Therefore, each permutation is a Bernoulli trial repre-
sented by (2) where x is the number of successes; N is the total
number of permutations; and p (p-value) is the proportion of all
success runs.
Pr p ¼ x
N
 
¼ N
x
 
pxð1 pÞNx: ð2Þ
In the ﬁrst experiment, we invoked HyGen using the top ten
MFR drugs as the seeds. The top ten MFR symptoms were identi-
ﬁed and ranked at upper 5% by HyGen with p-value less than
0.01 based on 104 permutations. In the second experiment, we
used the top ten MFR symptoms as the seeds. Based on the same
condition, HyGen identiﬁed the top ten MFR drugs with p-values
less than 0.01.
Another way to evaluate HyGen’s result is through Enrichment
Factor (EF), the ratio of the abundance of a particular entity in an
enriched environment to its abundance in the original environ-
ment. Based on this deﬁnition, the EF of the above two experimentscan be computed by (3) and (4) respectively. The top ten MFR
symptoms were identiﬁed with 36 fold enrichment. The top ten
MFR drugs were identiﬁed with 8 fold enrichment.abundance of FMR symptoms in HyGen result
abundance of FMR symptoms in the full graph
¼ 10=#sympotoms in top5%of the sub graph
symptoms in the full graph
¼ 36 ð3Þabundance of FMR drugs in HyGen result
abundance of FMR drugs in the full graph
¼ 10=#drugs in top5%of the sub graph
drugs in the full graph
¼ 8 ð4Þ
Those two simple evaluations boost our belief that HyGen could
use knowledge from the scientiﬁc domain to identify associations
relevant to health care practice. They also illustrate the potential
of HSNC as supplementary, empirical data sources for evaluating
bioinformatics tools.
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ALS is a complex disease, affected by many factors [34,35], such
as the multiple effects of single genes, the interaction of multiple
genes, and the interaction of genes with environment. HyGen’s
graph approach is suitable to study the intricate links among those
factors. Additionally, ALS is characterized by late onset and short
survival. Association and analysis of data fromunrelated individuals
are necessary because it is difﬁcult to obtain sufﬁcient number of
cases required for classical family-based studies. PLM has a large
number of ALS patients with diverse ethnic and environmental
backgrounds, thus it seems feasible to use its content in ALS re-
search. HSNC content can be utilized inmanyways; herewe explore
its potential of providing seeds for identifying ALS candidate genes.
We have converted PLM’s MFR terms into graph nodes. Instead
of using all of them as seeds, we decided to ﬁnd a systematic ap-
proach for selecting the optimal set of seeds. Based on detailed lit-
erature research, we deﬁned our gold standard to be 20 ALS genes
reported in some of the most salient studies to date [36–49]. In
Fig. 2, we have summarized them according to their publication
dates.Fig. 2. Important ALS genetic discov
Fig. 3. Plot the properties of 20 sub graphs in one chart. Each line in the chart representsWe conducted sets of experiments to study the effect of seeds
on HyGen’s ability to identify genes in the gold standard. A pool
of 20 seeds was derived from the top MFR terms in PLM commu-
nity reports. In each set of experiments, HyGen built 20 sub graphs
(G1–G20) with increasing number of seeds. For example, the ﬁrst
sub graph was constructed from only one seed: {x1}? G1; the sec-
ond sub graph was constructed with the previous seed plus a new
seed taken from the pool: {x1, x2}? G2; and {x1, x2, x3}? G3;. . .;
the last sub graph G20 was constructed from all 20 seeds.
Based on each sub graph, HyGen suggested a list of genes sorted
in descending order. We compared the top 5% genes in HyGen’s list
with our gold standard, and called the overlapping genes ‘‘hits’’. To
be a ‘‘hit’’, a gene not only has to be discovered by HyGen but also
has to be ranked at top 5%. Four properties: number of hits, number
of nodes, number of edges, and average degree were calculated for
sub graphs G1–G20 and plotted in one chart (see a sample in Fig. 3).
Each property p is represented by a line in the chart, and each point
(x, y) on the line corresponds to a sub graph Gi. The value of x is the
number of seeds used to build Gi, and y is a normalized value:
(px  pmin)/(pmax  pmin) with p being one of the four properties
of Gi.eries, used as the gold standard.
how the given property changes in the graphs built with increasing number of seeds.
Fig. 4. How the seeds affect the sub graphs and the hit rates. In (a), the seeds were
added in random order. In (b), the seeds were added in descending order of
prevalent. The charts demonstrate that (1) more seeds do not necessarily lead to
higher hit rate; and (2) well-chosen seeds can achieve higher hit rate with less seeds
and a smaller sub graph.
Table 4
Weights of the sources and criteria used during evaluation.
Weights assigned to each
criterion
Weights assigned to the sources
kC 1 OMIM 1.0 DrugMatrix 0.7
kS 0 KEGG 1.0 BioGRID 0.2
kT 1 DrugBank 0.6 GeneGo 0.5
kF 0 PharmGKB 0.4 WikiPathways 0.8
kL 1 Reactome 0.8 Panther 0.8
kR 0 GAD 0.5 Biobase 0.7
kP 1 NCI Nature Pathway 0.1 BIND 0.7
IPA 0.7 PID 0.5
MINT 0.5 IntAct 0.5
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sub graphs. Assuming the number of nodes and edges reﬂect the
size of a graph, and the average degree roughly corresponds to
the connectivity, such chart can be used to study how the seeds af-
fect the sub graph and its hit rate. There are 20 seeds in the pool,
hence, more than 2  1018 (20!) possible sets of experiments. We
analyzed 110 samples and observed that given more seeds, HyGen
did not necessarily achieve higher hit rate. When connectivity
grew rapidly, hit rate increased. In the chart, sharp climbs of aver-
age degree co-occurred with climbs of hit rate. In a sufﬁciently
large network, addition of low value seeds could negatively impact
the hit rate. Plateaus of average degree often co-occurred with the
dips of the hit rate, especially in the right-hand side of the chart.
Considering the origin of the seeds and HyGen’s design, those
trends are not difﬁcult to explain. All 20 seeds have been derived
from MFR terms reported by ALS patients. The fact that they have
emerged from thousands of other terms, suggests that they are
interrelated, central concepts in ALS knowledge space. Sharp
climbs of the connectivity indicate that the seeds added have ﬁlled
important knowledge gaps in the previous sub graphs. Such high
value seeds are more likely to increase hit rate. Plateaus of connec-
tivity indicate that the seeds added have not remarkably enriched
the knowledge in the sub graph. However, when the graph (net-
work) is large, adding a low value seed can still increase the net-
work’s complexity and negatively impact the hit rate. As shown
by the charts, HyGen becomes more susceptible to low value seeds
as the graph grows bigger. Such trend has also been observed when
applying HyGen to colorectal cancer (CRC) case studies. Both ALS
and CRC are complex diseases. Addition case studies in other dis-
ease areas are required to test whether this observation can be
generalized to other multi-system, complex diseases.
4.3. Recommendations on seed selection
Given n seeds, there are (2n  1) possible ways of selecting them
to build a sub graph. Based on the observation, we recommend
adding one seed at a time. Each addition should maximize the in-
crease of sub graph’s connectivity and minimize the increase of its
number of nodes and edges.When the connectivity stops increasing
after ith addition, tacking onmore seeds runs the danger of reducing
hit rate and {x1 . . . xi} may be the optimal set of seeds. If the preva-
lence of the seeds can not be inferred beforehand, up to (2n  1)
optimization experiments are needed since each addition is com-
pletely random. Therefore, it is beneﬁcial to estimate the prevalence
of the seeds based on independent sources or domain knowledge.
We hypothesize that prevalent terms in patient communities
are more relevant to their disease and consequently more valuable
seeds. Therefore, we extracted the number of patients who re-
ported each MFR term from PLM’s community reports and used
it as an indication of the seed’s prevalence. In Fig. 4, chart (a) rep-
resents the process where seeds were added in random order;
chart (b) represents the process where most prevalent seeds were
added ﬁrst. Comparing (a) and (b), we noticed that the average de-
gree increased more rapidly and a high hit rate was achieved with
smaller sub graphs when the seeds were selected based on their
prevalence in patient community.
When adding the seeds in descending order of their prevalence
as in (b), HyGen can identify 15 of the 20 published ALS genes (75%
hit rate) with the six drugs that are used by the most ALS commu-
nity members. The enhancement factor computed by (5) is 94
folds.
abundance of hits in HyGen result
abundance of hits in the full graph
¼ 15=#genes in top5%of the sub graph
20=#genes in the full graph
¼ 94 ð5ÞSince data in HSNC is often annotated by frequency, customer
votes, or other information that can be mined to infer the preva-
lence of a term. HSNC may be a promising data source for selecting
and optimizing seeds.
4.4. Sensitivity of the source weights
The weight of a source in HyGen’s user proﬁle reﬂects how
much the user value the information from this source, either in
Table 5
Candidate genes suggested by HyGen for future investigate.
Gene Reason for the suggestiona
MTHFR MTHFRh-relatedToDisease-iAcute leukemia {GAD}
Acute leukemiah-treatedBy-iRiluzole {DrugBank}
ALB ALBh-isTargetOf-iNortriptyline {DrugBank}
Nortriptylineh-treats-iDepressive disorder {DrugBank}
ADRA1A ADRA1Ah-isTargetOf-iMaprotiline {DrugBank}
Maprotilineh-treats-iDepressive disorder {DrugBank}
TNF TNFh-relatedToDisease-iAMYLOIDOSIS {GAD}
AMYLOIDOSISh-treatedBy-iRiluzole {DrugBank}
TP53 TP53h-relatedToDisease-iAcute leukemia {OMIM}
Acute leukemiah-treatedBy-iRiluzole {DrugBank}
ABCB1 ABCB1h-relatedToDisease-iDisorder, Bipolar {GAD}
Disorder, Bipolarh-treatedBy-iAmitriptyline {DrugBank}
GRIN1 GRIN1h-interactsWith-iDRD1{BKL_Proteome}
DRD1h-relatedToDisorder-iDepressive disorder {GAD}
CDKN2A CDKN2Ah-relatedToDisease-iAcute leukemia {OMIM}
Acute leukemiah-treatedBy-iRiluzole {DrugBank}
HRAS HRASh-relatedToDisease-iAcute leukemia {OMIM}
Acute leukemiah-treatedBy-iRiluzole {DrugBank}
BAALC BAALCh-relatedToDisease-iAcute leukemia {OMIM}
Acute leukemiah-treatedBy-iRiluzole {DrugBank}
ZFYVE26 ZFYVE26h-relatedToDisease-iclonus {OMIM}
clonush-treatedBy-iBaclofen {DrugBank}
a Reach row represents an association; the seeds are in bold font; data sources
are inside curly brackets; relationships are inside angle bracket.
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most valuable source, 0 the least. In all evaluations mentioned
above, we used the same set of source weights recommended by
domain experts (Table 4).
In the next set of experiments, we compared the hit rates of
HyGen using the same six drugs as seeds but different source
weights to test the sensitivity of the weight selection,. For each
of the 14 sources in Table 1, we tried eleven weights (0, 0.1,
0.2, . . ., 1.0) while keeping weights of all other sources at baseline
value of 0.5. Fig. 5 shows how the source weights affect the hit rate.
Only some sources are displayed in the plot. The sensitivity analy-
ses for all sources are available as Supplementary material. The
sensitivity analysis seems to imply that some of the ‘‘favored’’
sources did not improve hit rate. This might be caused by the fact
that the experts recommended the weight based on their experi-
ence which is a very subjective process. In the next study, we will
explore more objective process based on the sensitivity analysis
mentioned above.
5. Results
5.1. Highlighting candidates for ALS genetic study
Besides identifying the genes in the gold standard, HyGen has
also suggested genes that have not been reported or tested in ALS
studies. A few examples are included in Table 5 (the full list is in
the Supplementary ﬁle). Each gene has been suggested because it
has a hidden connection to at least one of the seeds. For example,
MTHFR has been highlighted based on the following reasoning:
genetic variation in MTHFR inﬂuences a person’s susceptibility
to acute leukemia according to Genetic Association Database
(GAD); and acute leukemia may be treated by riluzole according
to DrugBank. Riluzole’s mechanism of action is unknown, but it
may be related to MTHFR. Since riluzole is also the drug most
commonly taken by ALS patients, one possible hypothesis may
be that genetic variation in MTHFR could also inﬂuence one’s sus-
ceptibility to ALS. Based on this suggestion and the informatics
evidence, an expert may further investigate MTHFR’s potential
as a candidate for mutation screening in ALS. Furthermore, public
GWAS data of both ALS and acute leukemia may be mined to
identify the connection and interactions between MTHFR and
known ALS genes.
5.2. Linking riluzole with alcohol abuse
Starting from the optimal seeds, HyGen has identiﬁed other
interesting associations. For example, HyGen has suggested that
riluzole may be relevant to several conditions, including anxiety,
impulsive disorders and alcohol abuse. Riluzole’s pharmacologicalFig. 5. How weights of the sources affact hit rate.properties may include an inhibitory effect on glutamate release.
Thus it is not surprising that HyGen has connected riluzole with
anxiety and impulsive disorders, since glutamate system is an
important contributor to the pathophysiology of mood and anxiety
disorders. Such associations are not novel; using riluzole to treat
severe mood, anxiety and impulsive disorders was proposed in pa-
pers such as [50].
However, the association between alcohol abuse and riluzole
is more ‘‘interesting’’ and may inspire novel hypotheses. HyGen
has linked riluzole to alcohol abuse by two steps: hriluzole-
inhibits-NMDAi and hNMDA-related_to_disorder-alcoholismi.
Based on our literature research, HyGen’s suggestion appears
to be biologically relevant. Chronic alcohol ingestion increases
the binding of glutamate to NMDA receptors. During with-
drawal, a rebound activation of these receptors occurs and
causes alcohol withdrawal syndrome, such as seizures and
delirium tremens [51]. One may hypothesize that by inhibiting
NMDA, riluzole could relieve alcohol withdrawal syndrome and
reduce alcohol abuse problems. In fact, a recent animal study
found that riluzole can selectively reduce alcohol self-adminis-
tration and reduce the severity of alcohol withdrawal seizures
in mice [52]. This study was published after we have already
compiled all the associations in the full graph. Therefore, we
believe HyGen has identiﬁed the connection between riluzole
and alcohol abuse independently. It suggests that starting from
knowledge embedded in HSNC, HyGen can discover hidden
connections and suggest relevant hypotheses.6. Conclusion
Leveraging the rich patient-generated information embedded in
HSNC has presented challenges, as well as opportunities, to infor-
matics communities. We have made substantial enhancements to
a previous prototype and developed HyGen. This manuscript has
described the novel strategies used by HyGen to address the vari-
ous challenges in handling HSNC content, such as graph-based
Y.W Webster et al. / Journal of Biomedical Informatics 44 (2011) 536–544 543pseudo-relevancy feedback and proﬁle-driven sub-graphing. The
document has also presented the quantitative evaluations of
HyGen; discussed the effect of seeds on discovery rate; and
proposed an optimization method. Using the optimized seeds de-
rived from PLM, HyGen has identiﬁed 15 of the 20 genes proposed
by ALS studies. In addition, HyGen has suggested new candidate
genes for future investigations, as well as an interesting association
between riluzole and alcohol abuse.
One of the limitations of this study is the selection of the rank-
ing criteria. The criteria currently used by HyGen were selected
based on experience and literature review [53,54]. Most scientists
use HyGen in an iterative fashion: (1) initiate a search; (2) review
HyGen’s ﬁndings ranked at the top 5% based on the initial criteria;
(3) adjust seeds or criteria and repeat step (1). We currently do not
have a formal guideline for what criteria settings are suitable for
what type of search questions. To establish such a guideline, stud-
ies involving large number of pilot users, preferably scientists
interested in multiple disease areas, are necessary. We plan to pur-
sue this goal in the future.
Another limitation is that we only have access to the aggregated
community-level information provided by PLM. As the open re-
search model of HSNC continues to develop, it may be possible
to probe for associations at the individual-level using social science
methods. By sharing our preliminary results here, we hope to elicit
a greater interest within the bioinformatics community in the
development of novel methods to leverage HSNC content.Appendix A. Supplementary material
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.jbi.2011.01.010.
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